Research Beyond Borders overview
Learn more about how our Research Beyond Borders team is uncovering new ideas and new science.
Search
Ruminant parasite control in a nutshell
An exclusive drug-based approach to fight worms is dying. Dr. Ray Kaplan, from Georgia University, explains five things you need to know.
Diabetes dog symptoms chronic disease management
Learn about the symptoms of canine diabetes and how to manage the disease.
2019 performance: stronger foundation to absorb global effects of COVID-19 pandemic
2019 performance: stronger foundation to absorb global effects of COVID-19 pandemic
Local healthcare community raise alarm bells on growing trend of cardiovascular disease risk
Local healthcare community raise alarm bells on growing trend of cardiovascular disease risk factors associated with type 2 diabetes
Boehringer Ingelheim donates 75,000 doses of rabies vaccine
This significant rabies vaccine donation will support GARC’s efforts to address deaths due to rabies in Madagascar.
Boehringer Ingelheim appoints new Regional Managing Director
Boehringer Ingelheim appoints new Regional Managing Director
Bigger role in ensuring food security
As the world population is projected to reach 9.8 billion in 2050, animal health becomes fundamental to ensure both animal well-being and global protein supply.
Parasites: What your pets can’t tell you!
Learn how our team in the East & Southeast Asia approached the topic of pet parasite issues in the region.
Supporting Fundappas
Supporting Fundappas in Uruguay to improve quality of life of dogs and people.
Protein Degraders in Cancer
Boehringer Ingelheim scientists and their partners are exploring how protein degraders could bring so-called undruggable cancer targets within reach
Effective vaccine against most virulent strains of Marek's disease affecting poultry
Effective vaccine against most virulent strains of Marek's disease affecting poultry launched in Egypt
Boehringer Ingelheim Announces $1.14 Million Support for Lebanon
Boehringer Ingelheim Announces $1.14 Million Support for Lebanon
Mareks Disease Poultry Chicken
Five things you need to know to keep poultry free from outcomes of one of the most common virus affecting the animals’ immune systems.
FDA approves NexGard for the prevention Lyme disease in dogs
Boehringer Ingelheim received approval from the U.S. (FDA) to expand the label claims for NexGard, the chewable flea and tick product.
Boehringer Ingelheim Teams Up with the Lebanese Pulmonary Society (LPS) in its Fight against COVID-19
Boehringer Ingelheim Teams Up with the Lebanese Pulmonary Society (LPS) in its Fight against COVID-19
Cattle well-being at farms’ core
From pain management to responsible use of antibiotics, Cattle First introduces a whole cow approach to look after health and productivity.
It is about saving lives Alexis Jaliquias feline blood bank
Veterinarian Alexis Jaliquias founded one of the first blood banks for cats in South America
Industry 40 Innovation in France
Our sites in the Lyon area and Toulouse are investing in the industry of the future.
Uniting to stop rabies: a global and local endeavor
By collaborating together, we can stop rabies. Read how we are breaking down barriers through the power of partnerships to fight this deadly disease
Nepal: our efforts to fight against rabies year later
Nepal and our efforts to fight against rabies with our vaccination
EURORDIS Award
EURORDIS has selected Boehringer Ingelheim for the first time as recipient of the prestigious Black Pearl Award 2020
We need to keep our horses safe equine herpes virus
Interview with Head of Equine Liz Barrett on the recent outbreak of the Equine Herpes Virus in Europe
Bites that matter
The Bluetongue virus (BTV) is a worldwide infectious viral disease from the Reoviridae family known for its impact on domestic and wild ruminants' health and the economic loss it represents on trade. It doesn't affect humans, but it is a threat to animals
Boehringer Ingelheim Opens New Scientific Office in Kenya as Part of its Commitment to Improve Human and Animal Health in Africa
Boehringer Ingelheim has officially opened its new scientific office in Nairobi, Kenya.